Actively Recruiting
Therapeutic Endpoint in Pediatric IBD Conditions
Led by Children's National Research Institute · Updated on 2026-04-08
60
Participants Needed
1
Research Sites
209 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically subtypes Crohn's disease (CD) and ulcerative colitis (UC). The novel medical device evaluates the patient's sensory response to each of the three sensory nerve fiber types. Data from the device provides an assessment of disease activity and a more precise approach to treatment.
CONDITIONS
Official Title
Therapeutic Endpoint in Pediatric IBD Conditions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 6 years or older at screening
- Documented diagnosis of inflammatory bowel disease (IBD) based on medical history
You will not qualify if you...
- History of eye disease that prevents pupillometry
- Unwillingness or inability to participate due to developmental delays or ongoing psychological conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's National Health System
Washington D.C., District of Columbia, United States, 20010
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here